U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900816) titled 'A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001' on March 10.
Brief Summary: The purpose of this study is to evaluate the amount of the study drug, CHF6001, in the blood of adolescent patients with asthma in comparison to adult patients with asthma after a single oral dose of the study drug, CHF 6001.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
DRUG: CHF 6001
CHF 6001 DPI single dose
DRUG: CHF 6001
CHF 6001 DPI single dose
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chiesi Farmaceutici S.p.A.
...